Delivery Order SPE2DB24D2205-SPE2DB25FECVC
- Not listed
- The Defense Logistics Agency awarded a $5,168.16 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX under a firm fixed price contract, with an ultimate completion date of August 13, 2025. This is a non-set-aside, competitively awarded delivery order issued on July 23, 2025, with performance to be completed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on July 10, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $30,112.50 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of 200-unit vials of BOTOX under a firm fixed-price contract. The order is due for completion by July 31, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open...
- The Defense Logistics Agency awarded a delivery order valued at $21,534.00 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 unit vials, with an ultimate completion date of July 2, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a direct order fulfillment under the vendor's broader pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,936.00 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Botox Cosmetic under firm fixed price terms. The order, which was competitively awarded without a set-aside designation, is scheduled for completion by May 27, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for 200-unit vials of BOTOX with a ceiling value of $4,273.95. This competitively awarded, firm fixed-price delivery order represents part of AmerisourceBergen's broader pharmaceutical supply relationship with the federal government and is scheduled for completion by June 23, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX, valued at $4,306.80, on June 18, 2025, with an ultimate completion date of July 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100-unit vials, with a ceiling value of $2,153.40 and an ultimate completion date of June 24, 2025. This non-competitive delivery order carries firm fixed pricing and represents a competitive award under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX, valued at $3,419.20, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $10,257.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of BOTOX on June 27, 2025, with completion targeted for July 21, 2025. This non-competitive award, issued from the company's Conshohocken, Pennsylvania location, represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The award reflects routine medical procurement for federal healthcare systems, leveraging the...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FECVCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,336.32 to AmerisourceBergen Drug Corp for 100-unit vials of BOTOX on May 27, 2025, with completion targeted for June 17, 2025. This is a firm fixed-price delivery order under a non-competitive set-aside arrangement, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor in the federal medical procurement supply chain supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 5/27/25 |